Odds ratios (95% confidence intervals) for individual diagnostic components of MAFLD according to the MMD groups in males and femalesa
Variable | Group 1 (n=2,437) | Group 2 (n=2,363) | Group 3 (n=2,438) | Group 4 (n=2,306) |
---|---|---|---|---|
Male | ||||
Abdominal obesity by waist circumference |
1 | 0.68 (0.28–1.66) | 0.59 (0.21–1.63) | 1.02 (0.31–3.41) |
High blood pressure or drug medications |
1 | 1.04 (0.81–1.35) | 1.22 (0.94 –1.59) | 1.68 (1.25–2.25) |
High TG levels or specific drug medications |
1 | 2.48 (1.70–3.62) | 3.22 (2.20–4.72) | 5.91 (3.92–8.89) |
Low HDL-C levels or specific drug medications |
1 | 2.10 (1.31–3.36) | 2.79 (1.74–4.48) | 3.53 (2.13–5.86) |
Prediabetes |
1 | 1.22 (0.87–1.71) | 1.07 (0.75–1.51) | 1.19 (0.81-1.75) |
HOMA-IR ≥2.5 | NM | NM | NM | NM |
hsCRP >0.2 mg/dL | 1 | 1.81 (1.01–3.26) | 2.80 (1.57–5.00) | 2.74 (1.46–5.11) |
Fatty liver | 1 | 1.97 (1.41–2.74) | 3.09 (2.21–4.33) | 5.99 (4.14–8.68) |
Group 1 (n=440) | Group 2 (n=1,873) | Group 3 (n=1,758) | Group 4 (n=1,725) | |
---|---|---|---|---|
Female | ||||
Abdominal obesity by waist circumference |
1 | 1.22 (0.81–1.82) | 1.68 (1.10–2.57) | 1.93 (1.18–3.15) |
High blood pressure or drug medications |
1 | 1.09 (0.82–1.45) | 1.16 (0.86 –1.55) | 1.45 (1.05–2.01) |
High TG levels or specific drug medications |
1 | 1.34 (0.91–1.98) | 1.75 (1.17–2.62) | 1.84 (1.17–2.89) |
Low HDL-C levels or specific drug medications |
1 | 1.00 (0.77–1.28) | 1.08 (0.83–1.41) | 1.22 (0.91–1.63) |
Prediabetes |
1 | 1.20 (0.88–1.62) | 1.13 (0.82–1.55) | 1.05 (0.73–1.50) |
HOMA-IR ≥2.5 | 1 | 2.60 (0.76–8.86) | 1.92 (0.54–6.79) | 2.75 (0.75–10.07) |
hsCRP >0.2 mg/dL | 1 | 0.89 (0.56–1.41) | 1.21 (0.76–1.93) | 1.87 (1.14–3.07) |
Fatty liver | 1 | 1.50 (1.03–2.20) | 1.93 (1.30–2.86) | 2.70 (1.75–4.17) |
MAFLD, metabolic dysfunction-associated fatty liver disease; MMD, muscle mass deficit; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment-insulin resistance; hsCRP, high-sensitivity C-reactive protein; NM, not measurable; HbA1c, glycated hemoglobin.
aIn males, Group 1 is defined as MMD=0 kg; Group 2 is defined as 0 kg